AzTrials
AzTrials

Specific Learning DisorderNCT07843407

Investigation of Psychosocial Effects of Dance/Movement Therapy in Children With Specific Learning Disorders

A study testing Dance/Movement Therapy in people with Specific Learning Disorder, run by Lokman Hekim University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial examined whether dance/movement therapy (DMT) can improve emotional and social well-being in children with specific learning disorder (SLD). Children aged 8-12 years with SLD who were receiving special education services in Muğla, Türkiye, were randomly assigned to either an 8-week… Read more about this study

Who is it for?
Ages 8 to 12 years
Conditions the study is for
Specific Learning Disorder
What is being tested?
Dance/Movement Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Jun 2024to 15 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age 8-12 years
  • Diagnosis of specific learning disorder according to DSM-5 within the preceding 12 months, verified by a valid Child with Special Needs Report (ÇÖZGER)
  • Enrollment in a primary school affiliated with the Turkish Ministry of National Education, with at least one semester of formal schooling completed
  • Current enrollment in a special education and rehabilitation center

Who cannot join

  • Co-occurring physical, neurological, psychiatric, or other neurodevelopmental condition that could interfere with participation or substantially affect study outcomes
  • Receiving or initiating any treatment targeting neurodevelopmental, emotional, behavioral, or psychosocial functioning during the study period
  • Regular participation in organized sports or other structured physical activities outside routine school and recreational activities

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Yusuf İzzet Primary School

    Muğla, Fethiye, 48300

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of Psychosocial Effects of Dance/Movement Therapy in Children With Specific Learning Disorders: a Randomized Controlled Study With 6 Months Follow-up

This randomized controlled trial examined whether dance/movement therapy (DMT) can improve emotional and social well-being in children with specific learning disorder (SLD). Children aged 8-12 years with SLD who were receiving special education services in Muğla, Türkiye, were randomly assigned to either an 8-week group DMT program in addition to their usual special education services or to usual special education services alone. Anxiety and depressive symptoms, self-esteem, and social skills were assessed before the intervention, after the intervention, and at a 6-month follow-up.

Read the detailed description

Specific learning disorder is associated with emotional and social difficulties beyond academic problems. In this two-arm, parallel-group randomized controlled trial, eligible children were randomly allocated (1:1) to a DMT group or a control group using a computer-generated randomization sequence prepared by an independent statistician. The DMT program consisted of 16 group sessions (45 minutes each, twice weekly, over 8 weeks) delivered in small groups of 6-8 children. Each session followed a standardized five-phase structure (warm-up, improvisation, skill development, integration, and closure) based on the principles of the GAMZE (Gaining Accurate Mobility with Zealous Effort) style and the BrainDance model. Both groups continued to receive their usual special education services. Parents completed the Revised Child Anxiety and Depression Scale-Parent Version and the Social Skills Evaluation Scale, and children completed the Coopersmith Self-Esteem Inventory-School Form. Data were analyzed using linear mixed-effects models.

Being tested
Dance/Movement Therapy
Keywords
Dance/Movement Therapy, Specific Learning Disorder, Dance, Self-esteem, Anxiety, Depression, Social skills
Medical subject headings
Specific Learning Disorder, Anxiety Disorders, Depression, Social Skills

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dance/Movement TherapyBehavioural

    Also called DMT

    A structured, goal-oriented group program based on the GAMZE style and the BrainDance model. Each 45-minute session included warm-up (5 min), improvisation (10 min), skill development (15 min), integration (10 min), and closure (5 min). Sessions were delivered in groups of 6-8 children by an experienced therapist trained in goal-oriented DMT.

Study groups in NCT07843407
Study groupRoleWhat they receive
Dance/Movement TherapyExperimentalChildren received 16 sessions of group dance/movement therapy (45 minutes, twice weekly, for 8 weeks) in addition to their usual special education
Receives: Behavioral: Dance/Movement Therapy
ControlNo interventionChildren continued to receive their usual special education services without

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Revised Child Anxiety and Depression Scale-Parent Version (RCADS-P) Total Score

    Parent-reported 47-item scale assessing anxiety and depressive symptoms (total score range 0-141); higher scores indicate greater symptom severity.

    Measured: Baseline, week 8 (post-intervention), and month 6 (follow-up)

  2. Change in Coopersmith Self-Esteem Inventory-School Form (CSEI) Total Score

    Child-reported inventory assessing general, social, home/family, and academic self-esteem; higher scores indicate higher self-esteem.

    Measured: Baseline, week 8 (post-intervention), and month 6 (follow-up)

  3. Change in Social Skills Evaluation Scale (SSES) Total Score

    Parent-reported 69-item scale assessing social skills across 12 domains (total score range 69-345); higher scores indicate better social skills.

    Measured: Baseline, week 8 (post-intervention), and month 6 (follow-up)

Secondary outcomes (3)
  1. Change in RCADS-P Anxiety and Depression Subscale Scores

    Anxiety subscale (range 0-111) and depression subscale (range 0-30); higher scores indicate greater symptom severity.

    Measured: Baseline, week 8 (post-intervention), and month 6 (follow-up)

  2. Change in CSEI Subscale Scores

    General, social, home/family, and academic self-esteem subscales; higher scores indicate higher self-esteem.

    Measured: Baseline, week 8 (post-intervention), and month 6 (follow-up)

  3. Change in SSES Subscale Scores

    Twelve social skills domains; higher scores indicate better social skills.

    Measured: Baseline, week 8 (post-intervention), and month 6 (follow-up)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2026
  2. Study start15 Jun 2024
  3. Primary completion11 Mar 2025
  4. Study completion15 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07843407
Sponsor's protocol ID
LokmanHekimU-AGokcen-001
Status last verified
Sep 2026
First submitted
21 Sep 2026
Last updated
28 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data underlying the published results will be available from the corresponding author upon reasonable request after publication.

Questions about this trial

What is this clinical trial studying?

A study testing Dance/Movement Therapy in people with Specific Learning Disorder, run by Lokman Hekim University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Revised Child Anxiety and Depression Scale-Parent Version (RCADS-P) Total Score (time frame: Baseline, week 8 (post-intervention), and month 6 (follow-up)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in